Ticker	Volume	Price	Price Delta
DJIA	15,112.20	-206.04	-1.35%
S&P 500	1,628.93	-22.88	-1.39%
Nasdaq	3,443.20	-38.98	-1.12%

Ticker

Volume

Price

Price Delta

DJIA

15,112.20

-206.04

-1.35%

S&P 500

1,628.93

-22.88

-1.39%

Nasdaq

3,443.20

-38.98

-1.12%

Ticker	Volume	Price	Price Delta
STOXX 50	2,614.52	-69.46	-2.59%
FTSE 100	6,204.44	-144.38	-2.27%
DAX	7,992.49	-204.59	-2.50%

Ticker

Volume

Price

Price Delta

STOXX 50

2,614.52

-69.46

-2.59%

FTSE 100

6,204.44

-144.38

-2.27%

DAX

7,992.49

-204.59

-2.50%

Ticker	Volume	Price	Price Delta
Nikkei	13,014.60	-230.64	-1.74%
Hang Seng	20,382.90	-604.02	-2.88%
S&P/ASX 200	4,758.39	-102.99	-2.12%

Ticker

Volume

Price

Price Delta

Nikkei

13,014.60

-230.64

-1.74%

Hang Seng

20,382.90

-604.02

-2.88%

S&P/ASX 200

4,758.39

-102.99

-2.12%

Zhejiang Hisun, Pfizer to Form $295 Million Drug Venture

By Bloomberg News - 2011-06-03T01:37:25Z

Zhejiang Hisun Pharmaceutical Co. and Pfizer Inc. (PFE) agreed to form a $295 million venture to develop expired-patent drugs, according to a statement from the Chinese company to Shanghai’s stock exchange yesterday after markets closed.

To contact the editor responsible for this story: Gregory Turk at gturk2@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.